Every SmallCap Ideas report. Read on-site for free. Download the full Word version after email subscribe — we'll send the file and add you to the issue list.
A cleantech innovation engine where the parent's 48% equity plus 6% royalty in FDA-cleared Clyra Medical, validated at a $100M subsidiary valuation, may by itself be worth the parent's full market cap.
Non-invasive fingerprint sweat testing growing 36% YoY in fiscal H1 2026 while operating under a Nasdaq minimum-bid-price compliance window expiring June 15, 2026. FDA 510(k) is the binary catalyst.
A project-financed independent power producer with 23 battery storage projects across ERCOT, MISO, CAISO, and PJM. $250 million in committed strategic capital. No project at commercial operation yet.
Esports & gaming, drone manufacturers, mining-and-minerals juniors, EV component suppliers, and a crypto-infrastructure profile — all queued for the next issue. Subscribe to be notified.
Subscribe →